Journal
FEBS JOURNAL
Volume 274, Issue 18, Pages 4680-4687Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1742-4658.2007.05998.x
Keywords
attenuated live parasite; malaria; MSP1; Plasmodium; protective immunity; RTS/S; severe disease; transmission-blocking antibodies; vaccine; var2CSA
Categories
Ask authors/readers for more resources
Malaria vaccine discovery and development follow two principal strategies. Most subunit vaccines are designed to mimic naturally acquired immunity that develops over years upon continuous exposure to Plasmodium transmission. Experimental model vaccines, such as attenuated live parasites and transmission-blocking antigens, induce immune responses superior to naturally acquired immunity. The promises and hurdles of the different tracks towards an effective and affordable vaccine against malaria are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available